Fresenius Kabi unveils adenosine injection in prefilled syringesFresenius Kabi is the first company to offer adenosine in both vials and prefilled syringes. ANI Pharmaceuticals launches 2 genericsMethylphenidate hydrochloride extended-release tablets have a market value of roughly $505 million, and erythromycin ethylsuccinate for oral suspension has a market value of $16 million. CBD who’s who: ZuRI CBD Supply ZuRI offers more than 70 SKUs of CBD products, including wellness drops, topicals and pet items. CBD who’s who: Uleva Products Uleva Products offers full-spectrum hemp extract herbal supplements rich in phytocannabinoids to help support the body’s endocannabinoid system. Armas Pharmaceuticals launches 2 generics Armas Pharmaceuticals is introducing generic Xeloda and Gleevec, which had a market value of roughly $108 million and $655 million, respectively. FDA approves reintroduction of Sloan Pharma's Zelnorm Zelnorm was originally approved by the FDA in 2002 for the treatment of IBS-C in women Sun Pharma introduces Infugem Infugem is the first and only chemotherapy product in a premixed, ready-to-infuse formulation. Apotex reportedly considering a sale Apotex's business is valued at roughly $3 billion, according to a Bloomberg report. CBD who’s who: Prana Principle Prana Principle has been in the supplement industry for 24 years, and has a dedicated legal team that can answer questions regarding the legality of CBD. NCPA awaits forthcoming DIR drug pricing rule The National Community Pharmacists Association said it is hopeful the DIR rule will help fix pharmacy reimbursement issues. First Previous 534 535 536 537 538 Next Last
